Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Muliaditan

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Genome Research|December 2, 2024
Single-nucleus CUT&RUN elucidates the function of intrinsic and genomics-driven epigenetic heterogeneity in head and neck cancer progressionHoward J Womersley, Daniel Muliaditan, Ramanuj DasGupta, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 24, 2023
Melt-Encoded-Tags for Expanded Optical Readout in Digital PCR (METEOR-dPCR) Enables Highly Multiplexed Quantitative Gene Panel ProfilingDong Dong Liu, Daniel Muliaditan, Ramya Viswanathan, et al.
Bioinformatics (Oxford, England)|July 7, 2026
Detecting and reconstructing breakage-fusion-bridge cycles from long-read sequencing using BFBArchitectChaohui Li, Siavash Raeisi Dehkordi, Daniel Muliaditan, et al.
Palliative Medicine|October 2, 2018
Advance Care Planning for frail older adults: Findings on costs in a cluster randomised controlled trialAnouk Overbeek, Suzanne Polinder, Juanita Haagsma, et al.
Cancer Research|October 1, 2020
Specific Mechanisms of Chromosomal Instability Indicate Therapeutic Sensitivities in High-Grade Serous Ovarian CarcinomaNaoka Tamura, Nadeem Shaikh, Daniel Muliaditan, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Breakage fusion bridge cycles drive high oncogene copy number, but not intratumoral genetic heterogeneity or rapid cancer genome changeSiavash Raeisi Dehkordi, Ivy Tsz-Lo Wong, Jing Ni, et al.
Nature Communications|February 10, 2025
Breakage fusion bridge cycles drive high oncogene number with moderate intratumoural heterogeneitySiavash Raeisi Dehkordi, Ivy Tsz-Lo Wong, Jing Ni, et al.
Cell Reports. Medicine|April 5, 2025
CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancerShumei Chia, Justine Jia Wen Seow, Rafael Peres da Silva, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Genome Research|December 2, 2024
Single-nucleus CUT&RUN elucidates the function of intrinsic and genomics-driven epigenetic heterogeneity in head and neck cancer progressionHoward J Womersley, Daniel Muliaditan, Ramanuj DasGupta, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 24, 2023
Melt-Encoded-Tags for Expanded Optical Readout in Digital PCR (METEOR-dPCR) Enables Highly Multiplexed Quantitative Gene Panel ProfilingDong Dong Liu, Daniel Muliaditan, Ramya Viswanathan, et al.
Bioinformatics (Oxford, England)|July 7, 2026
Detecting and reconstructing breakage-fusion-bridge cycles from long-read sequencing using BFBArchitectChaohui Li, Siavash Raeisi Dehkordi, Daniel Muliaditan, et al.
Palliative Medicine|October 2, 2018
Advance Care Planning for frail older adults: Findings on costs in a cluster randomised controlled trialAnouk Overbeek, Suzanne Polinder, Juanita Haagsma, et al.
Cancer Research|October 1, 2020
Specific Mechanisms of Chromosomal Instability Indicate Therapeutic Sensitivities in High-Grade Serous Ovarian CarcinomaNaoka Tamura, Nadeem Shaikh, Daniel Muliaditan, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Breakage fusion bridge cycles drive high oncogene copy number, but not intratumoral genetic heterogeneity or rapid cancer genome changeSiavash Raeisi Dehkordi, Ivy Tsz-Lo Wong, Jing Ni, et al.
Nature Communications|February 10, 2025
Breakage fusion bridge cycles drive high oncogene number with moderate intratumoural heterogeneitySiavash Raeisi Dehkordi, Ivy Tsz-Lo Wong, Jing Ni, et al.
Cell Reports. Medicine|April 5, 2025
CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancerShumei Chia, Justine Jia Wen Seow, Rafael Peres da Silva, et al.
Pageof 1